Amjo Announces the Introduction of a New Stroke Therapy Device

The Biomove 3000 system was specifically developed for home therapy following a stroke. The highly affordable battery-powered device detects extremely small electrical EMG signals that persist in paralyzed muscles after a stroke and uses these tiny signals to initiate an electrical stimulation impulse to the muscles, resulting in actual muscle movement by the patient. FDA 510(k) approval allows Biomove 3000 to be marketed in the U.S., where over 700,000 individuals experience a stroke each year.

PRWeb (http://www.prweb.com/releases/2005/3/prweb221714.htm)